Company profile
Molecular Partners AG
Wagistrasse 14
8952 Zurich-Schlieren
Switzerland
8952 Zurich-Schlieren
Switzerland
Biotechnology
Oncology
Virology
Biotech
Molecular Partners AG is a clinical-stage biopharmaceutical company that is developing a new class of biological therapies known as DARPin® therapies. Molecular Partners has compounds in various stages of clinical and preclinical development, with a current focus on oncology and infectious diseases. DARPins are a new class of protein therapeutics that could potentially overcome limitations of current protein-based therapeutics and enable new ways of treating diseases.
Contact
